Ferro-F-Tab was listed on the PBS after the deletion of FGF (ferrous sulfate 250 mg with folic acid 300 micrograms) on 1 April 2005. The Pharmaceutical Benefits Advisory Committee (PBAC) considered it appropriate that such a product be available for concessional status patients and Indigenous Australians.
Ferro-F-Tab is used to prevent and treat iron and folate deficiency, particularly during pregnancy and in megaloblastic anaemia. Do not start these tablets until vitamin B12 deficiency has been excluded — they do not prevent the neurological damage that B12 deficiency may cause.
Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.
